RNA medicines can target any gene or protein in humans and so can be used to treat diseases that cannot be treated by conventional drugs such as small molecules and biologics.
Our bodies and cells are made up of many different proteins. Diseases occur when genes and proteins inside our bodies malfunction. DNA contains the genetic code needed for cells to make proteins. Various types of RNA, including messenger RNA (mRNA), small interfering RNA (siRNA) and microRNA, work together to control how the genes contained in our DNA are translated into proteins.
Arcturus’ proprietary UNA Oligomer and LUNAR™ delivery technologies can be used to make all classes of RNA medicines safe and effective.
March 11, 2018
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
March 9, 2018
Arcturus Therapeutics to Present at Bio Europe on March 13th
March 5, 2018
Arcturus Therapeutics Calls on Proposed Director Nominees to Respond to Constructive Board Outreach